Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-10-14 00:00:00 ET · period of report 2025-10-10 · accession 0001185945-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-14 | 2025-10-10 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $9.24 | -1,775 | 57.1K | -3% | -$16.4K |
| D | 2025-10-14 | 2025-10-10 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $1.23 | +4,062 | 58.9K | +7% | +$4,996 |
| D | 2025-10-14 | 2025-10-10 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $1.23 | -4,062 | 174.3K | -2% | -$4,996 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-10-10 | S | D | 1,775 | $9.24 | 57,079 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2025-10-10 | M | A | 4,062 | $1.23 | 58,854 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025. |
| 3 | Derivative | Common Shares | 2025-10-10 | M | D | 4,062 | $1.23 | 174,344 | D | $1.23 · 2015-11-10 to 2025-11-10 | 4,062 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025. |